Danazole in the treatment of hereditary angioedema.

Published

Journal Article (Review)

Danazol is an effective agent for the prophylaxis of the recurrent attacks of mucocutaneous and visceral swelling which occur in patients with hereditary angioedema (HAE). Danazol apparently increases the synthesis of the inhibitor of the first component of complement which is partially deficient in these heterozygous individuals. The efficacy of danazol in this condition appears to be limited only by the occurrence of adverse effects.

Full Text

Cited Authors

  • Hosea, SW; Frank, MM

Published Date

  • May 1, 1980

Published In

Volume / Issue

  • 19 / 5

Start / End Page

  • 370 - 372

PubMed ID

  • 6993183

Pubmed Central ID

  • 6993183

International Standard Serial Number (ISSN)

  • 0012-6667

Digital Object Identifier (DOI)

  • 10.2165/00003495-198019050-00007

Language

  • eng

Conference Location

  • New Zealand